Category: Studies

Study: Psilocybin May Produce “Lasting Improvements in Mental Health Symptoms and General Wellbeing”

Results of a study published in the journal Frontiers in Psychiatry “indicate broad therapeutic potential of psilocybin to produce lasting improvements in mental health symptoms related to anxiety, depression, and substance misuse”. Additionally, the study states that “psilocybin seems capable of producing enduring changes in psychological functioning and personality such as increased cognitive flexibility, emotion …

Continue reading

Study Finds Marijuana Extracts Associated With Sustained Improvements in Those With Chronic Health Conditions

Marijuana extracts are associated with health-related quality of life improvements in patients suffering from chronic conditions such as pain, fatigue and anxiety, according to a study published in the journal PLOS One. For the study researchers examined the efficacy of marijuana extracts in a cohort of over 2,300 patients (aged 18 to 97) who are authorized …

Continue reading

Study: CBD Inhibits the Proliferation and Invasiveness of Prostate Cancer Cells

According to a new study, “the ability of CBD to inhibit prostate cancer cell proliferation and invasiveness suggests that CBD may have potential as a future chemotherapeutic agent.” Conducted by researchers at the University College Dublin, the study is being published in the newest issue of the Journal of Natural Products, with it published online …

Continue reading

Study: Tobacco Users, But Not Marijuana Users, Have Greater Odds for Complications Following Ankle Injury

A study conducted at the Yale School of Medicine found that those who use marijuana but not tobacco were not at greater odds of an adverse event up to 90 days following an ankle injury. “Ankle fractures are common orthopaedic injuries that may be indicated for open reduction internal fixation (ORIF)”, states the study, published …

Continue reading

New Study Highlights Role of Psychedelics in Protecting Mental Health During COVID-19 Pandemic

A landmark study recently published in the journal Scientific Reports under the umbrella of Nature, offers new insights into the potential benefits of psychedelics on mental well-being during the challenging circumstances of the COVID-19 pandemic. The research, conducted collaboratively by several institutions, including ICEERS, Universitat Rovira i Virgili, the University of São Paulo at Ribeirão …

Continue reading

Study: CBD Blocks Development of Breast Cancer Tumors In Vivo

Results of a new study “confirm that in vivo CBD blocks development of breast cancer tumors formed by cells induced to malignancy by IL-1β, endorsing its therapeutic potential for cancer treatment.” Conducted by researchers at the Avenida Instituto Politécnico Nacional and Universidad Nacional Autónoma de México, the study was published by the International Journal of …

Continue reading

Study Finds Marijuana Extracts Associated with Quality of Life Improvements in Those With Autism

According to a study published in the journal Frontiers in Psychiatry, autistic patients who use marijuana-based extracts experience symptom improvements and a reduction in the use of prescription medications. The study was conducted by researchers at the National Association for Inclusion of the Autistic People, the University of Brasilia, the Federal University of Minas Gerais, the Euro-American …

Continue reading

Study: Topical CBD Gel an “Effective Candidate For an Anti-Inflammatory Agent”

 The topical administration of 1% CBD gel “is a potentially effective candidate for an anti-inflammatory agent”, states a new study using animal models. The study is being published in the October issue of the peer-reviewed journal Cannabis and Cannabinods Research, and it was pubished online ahead of print by the US National Library of Medicine. …

Continue reading

Study: Psilocybin Treatment Associated With “Clinically Significant Sustained Reduction in Depressive Symptoms”

In a new study a single dose of psilocybin was associated “with a clinically significant sustained reduction in depressive symptoms and functional disability”, with minimal side effects. Published by the American Medical Association, the objective of the study was to “evaluate the magnitude, timing, and durability of antidepressant effects and safety of a single dose …

Continue reading

Clinical Trial: High-CBD Marijuana Doesn’t Negatively Impact Driving Performance, But THC Could be Detected Hours Later

Consuming high-CBD/low-THC marijuana doesn’t adversely impact driving abilities, but THC may be detected up to five hours after, according to clinical trial data published in the International Journal of Legal Medicine. Conducted by researchers at the  University of Basel, the aim of this “prospective, placebo-controlled, double-blind, randomized, cross-over study was to determine cannabinoid levels in …

Continue reading